High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial
Research output: Contribution to journal › Journal article › Research › peer-review
Original language | English |
---|---|
Journal | Leukemia and Lymphoma |
Volume | 55 |
Issue number | 5 |
Pages (from-to) | 1206-1208 |
Number of pages | 3 |
ISSN | 1042-8194 |
DOIs | |
Publication status | Published - 2014 |
- Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cytarabine, Humans, Lymphoma, Mantle-Cell, Treatment Failure, Treatment Outcome
Research areas
ID: 138501270